FDA — authorised 31 October 2000
- Application: NDA021183
- Marketing authorisation holder: BRISTOL MYERS SQUIBB
- Local brand name: VIDEX EC
- Indication: CAPSULE, DELAYED REL PELLETS — ORAL
- Status: approved
FDA authorised Videx EC on 31 October 2000
Yes. FDA authorised it on 31 October 2000.
BRISTOL MYERS SQUIBB holds the US marketing authorisation.